Published in J Inherit Metab Dis on February 19, 2007
Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain (2009) 1.59
Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab (2010) 1.52
Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr (2011) 1.27
The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis (2013) 1.07
Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series. Pediatr Transplant (2010) 1.05
Phenylbutyrate therapy for maple syrup urine disease. Hum Mol Genet (2010) 1.05
Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. Hum Mol Genet (2014) 0.91
Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis (2013) 0.85
Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis (2014) 0.84
Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. J Inherit Metab Dis (2010) 0.79
Mitochondrial metabolites extend lifespan. Aging Cell (2016) 0.79
Serum Markers of Neurodegeneration in Maple Syrup Urine Disease. Mol Neurobiol (2016) 0.76
Developmental Defects of Caenorhabditis elegans Lacking Branched-chain α-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency. J Biol Chem (2015) 0.75
Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease. Mol Genet Metab Rep (2015) 0.75
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 5.79
The molecular basis of lung morphogenesis. Mech Dev (2000) 4.87
Differential abscisic acid regulation of guard cell slow anion channels in Arabidopsis wild-type and abi1 and abi2 mutants. Plant Cell (1997) 3.62
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol (1995) 3.34
The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem Biol (1998) 3.23
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46
hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family. FEBS Lett (2000) 2.40
Positional cloning of heart and soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol (2001) 2.16
Cystic fibrosis, Young's syndrome, and normal sweat chloride. Lancet (1998) 2.06
Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Ann Hematol (2003) 2.01
Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry (2008) 1.92
Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nat Med (1995) 1.87
Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem (1996) 1.87
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation (1993) 1.86
The isolation of porcine ribonuclease, a glycoprotein, from pancreatic juice. J Biol Chem (1968) 1.83
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib. Leukemia (2013) 1.77
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res (2001) 1.69
Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest (1998) 1.68
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis (2009) 1.58
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med (Berl) (2001) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J (2000) 1.48
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr (1984) 1.47
Late evaluation of pulmonary function after acute exposure to chlorine gas. Am Rev Respir Dis (1969) 1.46
Retrovirus-induced insertional mutation in Mov13 mice affects collagen I expression in a tissue-specific manner. Cell (1989) 1.46
Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics (2000) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
Evidence for a non-orthostatic origin of orthostatic tremor. J Neurol Neurosurg Psychiatry (1999) 1.43
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Evaluation of different tubing geometries for high-speed counter-current chromatography. J Chromatogr A (2001) 1.39
[Cerebral angiitis or central side effects after lumbar myelography (with intracerebral vascular spasm)]. Nervenarzt (1994) 1.38
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib. J Magn Reson Imaging (2001) 1.37
Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. Lancet (1990) 1.36
Genetic selection of mutations in the high affinity K+ transporter HKT1 that define functions of a loop site for reduced Na+ permeability and increased Na+ tolerance. J Biol Chem (1999) 1.34
High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol (1997) 1.33
Prevalence of antibodies to West Nile fever, sandfly fever Sicilian, and sandfly fever Naples viruses in healthy adults in Israel. Public Health Rev (1999) 1.33
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis (2009) 1.30
Precision grip and Parkinson's disease. Brain (1998) 1.29
Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation (2008) 1.28
Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet (1992) 1.27
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res (2006) 1.25
Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci U S A (1997) 1.25
CSF shunt infections in children. Infection (1993) 1.22
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
Different mechanisms underlie the long-latency stretch reflex response of active human muscle at different joints. J Physiol (1991) 1.21
The role of the human thalamus in processing corollary discharge. Brain (2005) 1.19
Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol (1998) 1.18
Halictine social evolution: the Australian enigma. Science (1976) 1.17
Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology (1988) 1.15
Clinic experience of prenatal diagnosis of cystic fibrosis by use of linked DNA probes. Lancet (1987) 1.15
Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene (2001) 1.14
Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene (2009) 1.13
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur J Clin Invest (2004) 1.13
[Securing the airway in children with the Morquio-Brailsford syndrome]. Anaesthesist (1993) 1.13
Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets. Hepatology (1998) 1.13
Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry (1998) 1.13
The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis (1999) 1.12
DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet (1989) 1.12
The b-wave of the electroretinogram as an index of retinal ischemia. Gen Pharmacol (1998) 1.10
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09
Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation (1994) 1.09
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem (1995) 1.08
Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc Natl Acad Sci U S A (1991) 1.08
Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts. Clin Chim Acta (1973) 1.07
Characterization of human Kv4.2 mediating a rapidly-inactivating transient voltage-sensitive K+ current. Receptors Channels (1999) 1.07
Learned changes of feeding behavior in Aplysia in response to edible and inedible foods. J Neurosci (1986) 1.06
The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone (2005) 1.06
Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur J Hum Genet (2000) 1.06
Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen. Carcinogenesis (1990) 1.05
Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta (1983) 1.05
Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem J (2001) 1.04
Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus (2006) 1.04
p53 Mutations in human hepatocellular carcinomas from Germany. Cancer Res (1992) 1.04
Variant maple syrup urine disease (MSUD)--the entire spectrum. J Inherit Metab Dis (2006) 1.04
Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology (1996) 1.04
Pregnancy in a woman with maple syrup urine disease. J Inherit Metab Dis (1998) 1.03
Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res (1992) 1.03
Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol (2001) 1.03
Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res (1981) 1.02
Cerebral hemispheric low-flow infarcts in arterial occlusive disease. Lesion patterns and angiomorphological conditions. Stroke (1997) 1.02
Evidence for impaired gluconeogenesis in very long-chain acyl-CoA dehydrogenase-deficient mice. Horm Metab Res (2006) 1.02
Alpha-ketoadipic aciduria: degradation studies with fibroblasts,. Clin Chim Acta (1975) 1.02
Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab (2004) 1.02
Bovine pericardium for duraplasty: clinical results in 32 patients. Neurosurg Rev (2001) 1.01
Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol (1993) 1.01
Precision grip deficits in cerebellar disorders in man. Clin Neurophysiol (2001) 1.00
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Cancer (2003) 1.00
Difficulties in making the diagnosis of Hirschsprung disease in early infancy. J Paediatr Child Health (2004) 1.00
Sex pheromone of the Asian corn borer moth. Life Sci (1980) 1.00
A patient with alpha-ketoadipic and alpha-aminoadipic aciduria. J Inherit Metab Dis (1984) 0.99
Automatic acquisition of fiducial markers and alignment of images in tilt series for electron tomography. J Electron Microsc (Tokyo) (1999) 0.99
Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta (1975) 0.99
Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment. J Inherit Metab Dis (2008) 0.99